Interestingly, alterations in both PLCβ1 and PI3K/Akt/mTOR pathways have been associated with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) [57,83,84]. The gene discussed is MTOR; the disease is acute myeloid leukemia.